EXHIBIT 99.13
-------------
THIS WARRANT AND ANY SHARES OF COMMON STOCK ISSUED UPON EXERCISE HEREOF HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND HAVE BEEN
ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE
OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISPOSITION MAY BE EFFECTED WITHOUT AN
EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL
SATISFACTORY IN FORM AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT
REQUIRED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
WARRANT NO. 3
THIS CERTIFIES THAT, for value received FKA DISTRIBUTING CO., d/b/a
HOMEDICS, INC., a Michigan corporation or its assigns ("HOMEDICS" or "HOLDER")
is entitled to, within the time frame set forth in Section 2 below, but not
thereafter, to subscribe for, purchase and receive up to Twenty Six Million Five
Hundred Seven Thousand Six Hundred Fifty Eight (26,507,658) fully paid and
non-assessable shares of the common stock (the "COMMON STOCK") of KRONOS
ADVANCED TECHNOLOGIES, INC., a Nevada corporation (the "COMPANY"), at a purchase
price per share (the "EXERCISE PRICE") as set forth in Section 1 below, upon the
terms and subject to the conditions set forth in this Warrant. Such number of
shares, type of security and Exercise Price are subject to adjustment as
provided herein, and all references to "Common Stock" and "Exercise Price"
herein shall be deemed to include any such adjustment or series of adjustments.
This Warrant is issued by the Company pursuant to the terms of the First
Amendment to Master Loan and Investment Agreement between the Company and
HoMedics dated October 25, 2004 (the "AMENDED LOAN AGREEMENT"). The Company is
issuing Amended and Restated Warrant Nos. 1 and 2 ("WARRANT NOS. 1 AND 2") to
HoMedics on the date hereof, which amend and restate original Warrant Nos. 1 and
2 that the Company issued to HoMedics on May 9, 2003.
1. EXERCISE PRICE.
Subject to adjustments as provided herein, the Exercise Price per share of
Common Stock subject to this Warrant shall be equal to $0.10 per share.
2. EXERCISE OF WARRANT.
(a) EXPIRATION DATE; PROCEDURE FOR EXERCISE. The purchase rights
represented by this Warrant are exercisable by the Holder, in whole or in part,
at any time from the date hereof and up to and including October 25, 2014 (the
"EXPIRATION DATE"), by the surrender of this Warrant and the Notice of Exercise
form attached hereto duly executed to the office of the Company at 464 Common
Street, Suite 301, Belmont, MA 02478-2570 (or such other office or agency of the
1
Company as it may designate by notice in writing to the Holder at the address of
the Holder appearing on the books of the Company), and upon payment of the
Exercise Price for the shares thereby purchased (by cashier's check or wire
transfer in an amount equal to the purchase price of the shares thereby
purchased or in accordance with the cashless exercise provision set forth in
Section 2(b)); whereupon the Holder shall be entitled to receive from the
Company a stock certificate representing the number of shares of Common Stock so
purchased, and a new Warrant in substantially identical form and dated as of
such exercise for the purchase of that number of shares of Common Stock equal to
the difference, if any, between the number of shares of Common Stock subject
hereto and the number of shares of Common Stock as to which this Warrant has
been exercised.
(b) Cashless Exercise. Notwithstanding any provisions herein to the
contrary, if the fair market value (as defined in Section 3 hereof) of one share
of the Company's Common Stock is greater than the Exercise Price (at the date of
calculation as set forth below), in lieu of exercising this Warrant for cash,
the Holder may elect to receive shares equal to the value (as determined below)
of this Warrant (or the portion thereof being canceled) by surrender of this
Warrant at the principal office of the Company (together with the properly
endorsed Notice of Exercise) in which event the Company shall issue to the
Holder a number of shares of Common Stock computed using the following formula:
X= Y (A-B)
--------
A
Where X = the number of shares of Common Stock to be
issued to the Holder
Y = the number of shares of Common Stock
purchasable under the Warrant or, if only
a portion of the Warrant is being
exercised, the portion of the Warrant
being canceled (at the date of such
calculation)
A = the fair market value of one share of the
Company's Common Stock (at the date of
such calculation)
B = Exercise Price (as adjusted to the date of
such calculation)
In the Amended Loan Agreement, HoMedics has agreed that it will not
exercise any portion of this Warrant by means of a cashless exercise or
otherwise for one year following the effective date of the registration
statement that the Company plans to file with the SEC for the resale of certain
shares that the Company plans to issue to Cornell Capital Partners, LP. The
Company plans to file this registration statement with the SEC on or about
November 25, 2004.
2
3. ISSUANCE OF SHARES; NO FRACTIONAL SHARES.
Certificates for shares purchased hereunder shall be delivered to the
Holder hereof within a reasonable time (in no event exceeding ten (10) business
days) after the date on which this Warrant shall have been exercised in
accordance with the terms hereof. The Company agrees that the shares so issued
shall be, and shall for all purposes be deemed to have been, issued to the
Holder as the record owner of such shares as of the close of business on the
date on which this Warrant shall have been exercised or converted in accordance
with the terms hereof. No fractional shares or scrip representing fractional
shares shall be issued upon the exercise of this Warrant. With respect to any
fraction of a share called for upon the exercise of this Warrant, an amount
equal to such fraction multiplied by the fair market value of a share of Common
Stock on the date of exercise shall be paid in cash or check to the holder of
this Warrant (fair market value shall be the average closing price of a share of
Common Stock on the OTC BB, or any other quotation system or stock exchange on
which the Common Stock is quoted or listed at the time of exercise, as reported
in "The Wall Street Journal" over the five consecutive business days immediately
prior to surrender of this Warrant pursuant to Section 2 above).
4. REPRESENTATIONS AND COVENANTS OF THE COMPANY.
(a) NO LIENS. The Company hereby represents and warrants that all
shares of Common Stock which may be issued upon the exercise of this Warrant
will, upon such exercise, be duly and validly authorized and issued, fully paid
and nonassessable and free from all taxes, liens and charges in respect of the
issuance thereof (other than liens or charges created by or imposed upon the
Holder) and not subject to preemptive or any similar rights of the stockholders
of the Company.
(b) RESERVATION OF STOCK. As soon as practicable after execution of
this Warrant, the Company will reserve sufficient authorized but unissued Common
Stock to enable it to satisfy its obligations on exercise of this Warrant and
will, if necessary, reserve additional shares of Common Stock during the period
in which this Warrant may be exercised to satisfy its obligations hereunder. If
at any time the Company's authorized Common Stock shall not be sufficient to
allow the exercise of this Warrant, the Company shall take such corporate action
as may be necessary to increase its authorized but unissued Common Stock to be
sufficient for such purpose.
(c) FURNISH INFORMATION. The Company agrees to promptly deliver to the
Holder copies of all financial statements, reports and proxy statements which
the Company shall have sent to its stockholders generally.
(d) RULE 144. In order to permit the Holder to sell the Common Stock
issuable upon exercise of the Warrant pursuant to Rule 144 under the 1933 Act
(or any successors to such rules), the Company will comply with all rules and
regulations of the Commission applicable in connection with use of each of Rule
144 (or any successor thereto), including the timely filing of all reports with
3
the Commission in order to enable the Holder, if it so elects, to utilize Rule
144.
5. NO RIGHTS AS SHAREHOLDERS.
This Warrant does not entitle the Holder to any voting rights or other
rights as a stockholder of the Company prior to the exercise hereof.
6. TRANSFERABILITY.
(a) RESTRICTIONS ON WARRANT. This Warrant shall only be transferable
if the Holder complies with applicable exemptions under the Securities Act of
1933, as amended (the "1933 ACT") and applicable state securities laws.
(b) RESTRICTIONS ON COMMON STOCK ISSUABLE UPON EXERCISE. In no event
will the Holder make a disposition of the Common Stock issuable upon exercise of
this Warrant unless and until (i) it shall have notified the Company of the
proposed disposition, and (ii) if requested by the Company, it shall have
furnished the Company with an opinion of counsel satisfactory to the Company and
its counsel to the effect that (A) appropriate action necessary for compliance
with the 1933 Act provisions relating to sale of an unregistered security has
been taken, or (B) an exemption from the registration requirements of the 1933
Act is available. Notwithstanding the foregoing, the restrictions imposed upon
the transferability of the Common Stock issuable on the exercise of this Warrant
shall terminate as to any particular share of Common Stock when (1) such
security shall have been sold without registration in compliance with Rule 144
under the 1933 Act, or (2) a letter shall have been issued to the Holder at its
request by the staff of the Securities and Exchange Commission or a ruling shall
have been issued to the Holder at its request by such Commission stating that no
action shall be recommended by such staff or taken by such Commission, as the
case may be, if such security is transferred without registration under the 1933
Act in accordance with the conditions set forth in such letter or ruling and
such letter or ruling specifies that no subsequent restrictions on transfer are
required, or (3) such security shall have been registered under the 1933 Act and
sold by the Holder thereof in accordance with such registration.
(c) RESTRICTIVE LEGEND. The Company may place a legend describing, in
whole or in part, the restrictions imposed by sub-sections (a) and (b) to this
Section 6 on this Warrant, any replacement Warrant and on any certificate
representing the Common Stock issuable upon exercise of this Warrant. Whenever
such restrictions shall terminate, the Holder of a share of Common Stock issued
upon exercise of this Warrant as to which such restrictions have terminated
shall be entitled to receive from the Company one or more new certificates for
such shares of Common Stock not bearing the restrictive legend.
7. LOSS, THEFT, DESTRUCTION OR MUTILATION OF WARRANT.
On receipt by the Company of evidence reasonably satisfactory to the
Company of the loss, theft, destruction or mutilation of this Warrant, the
Company will execute and deliver to the Holder, in lieu thereof, a new warrant
4
in substantially identical form, dated as of the date of such cancellation and
reissuance.
8. SATURDAYS, SUNDAYS AND HOLIDAYS.
If the last or appointed day for the taking of any action or the
expiration of any right required or granted herein shall be a Saturday or a
Sunday or shall be a legal holiday, then such action may be taken or such right
may be exercised on the next succeeding business day.
9. CERTAIN ADJUSTMENTS.
The Exercise Price and number of shares issuable upon exercise of this
Warrant are subject to adjustment from time to time as set forth in this Section
9. Upon each such adjustment of the Exercise Price pursuant to this Section 9
(a), (b), (c) or (d), the Holder shall thereafter prior to the Expiration Date
be entitled to purchase, at the Exercise Price resulting from such adjustment,
the number of shares obtained by multiplying the Exercise Price in effect
immediately prior to such adjustment by the number of shares issuable upon
exercise of this Warrant (together with any additional warrants issued pursuant
to Section 9(e)) immediately prior to such adjustment and dividing the product
thereof by the Exercise Price resulting from such adjustment.
(a) STOCK SPLITS AND DIVIDENDS. If the Company, at any time while this
Warrant is outstanding, (i) shall pay a stock dividend or otherwise make a
distribution or distributions on shares of its Common Stock or on any other
class of capital stock payable in shares of Common Stock, (ii) subdivide
outstanding shares of Common Stock into a larger number of shares, or (iii)
combine outstanding shares of Common Stock into a smaller number of shares, the
Exercise Price shall be adjusted by multiplying the Exercise Price in effect on
the record date for such event by a fraction of which the numerator shall be the
number of shares of Common Stock (excluding treasury shares, if any) outstanding
immediately before such event and of which the denominator shall be the number
of shares of Common Stock (excluding treasury shares, if any) outstanding after
such event. Any adjustment made pursuant to this Section 9(a) shall become
effective immediately after the record date for the determination of
stockholders entitled to receive such dividend or distribution and shall become
effective immediately after the effective date in the case of a subdivision or
combination, and shall apply to successive subdivisions and combinations.
(b) RECLASSIFICATIONS AND SHARE EXCHANGES. In case of any
reclassification of the Common Stock or any compulsory share exchange pursuant
to which the Common Stock is converted into other securities, cash or property,
then the Holder shall have the right thereafter to exercise this Warrant
(together with any additional warrants issued pursuant to Section 9(e)) only
into the shares of stock and other securities and property receivable upon or
deemed to be held by holders of Common Stock following such reclassification or
share exchange, and the Holder shall be entitled upon such event to receive such
amount of securities or property equal to the amount of shares such Holder would
have been entitled to receive had such Holder exercised this Warrant (together
with any additional warrants issued pursuant to Section 9(e)) immediately prior
5
to such reclassification or share exchange. The terms of any such
reclassification or share exchange shall include such terms so as to continue to
give to the Holder the right to receive the securities or property set forth in
this Section 9(b) upon any exercise following any such reclassification or share
exchange.
(c) DISTRIBUTIONS OF EVIDENCES OF INDEBTEDNESS, ASSETS OR RIGHTS. If
the Company, at any time while this Warrant (together with any additional
warrants issued pursuant to Section 9(e)) is outstanding, shall distribute to
all holders of Common Stock (and not to the Holder of this Warrant) evidences of
its indebtedness or assets or rights or warrants to subscribe for or purchase
any security (excluding those referred to in Sections 9(a), (b) and (d)), then
in each such case the Exercise Price shall be adjusted by multiplying the
Exercise Price in effect immediately prior to the record date fixed for
determination of stockholders entitled to receive such distribution by a
fraction of which the denominator shall be the Exercise Price determined as of
the record date mentioned above, and of which the numerator shall be such
Exercise Price on such record date less the then fair market value at such
record date of the portion of such assets or evidence of indebtedness so
distributed applicable to one outstanding share of Common Stock as determined by
the Company's independent certified public accountants that regularly audits the
financial statements of the Company (an "APPRAISER").
(d) MERGERS AND CONSOLIDATIONS. In case of any (1) merger or
consolidation of the Company with or into another Person, or (2) sale by the
Company of more than one-half of the assets of the Company (on a book value
basis) in one or a series of related transactions, the Holder shall have the
right thereafter to exercise this Warrant (together with any additional warrants
issued pursuant to Section 9(e)) for the shares of stock and other securities,
cash and property receivable upon or deemed to be held by holders of Common
Stock following such merger, consolidation or sale, and the Holder shall be
entitled upon such event or series of related events to receive such amount of
securities, cash and property as the Common Stock for which this Warrant
(together with any additional warrants issued pursuant to Section 9(e)) could
have been exercised immediately prior to such merger, consolidation or sale
would have been entitled. The terms of any such merger, sale or consolidation
shall include such terms so as continue to give the Holder the right to receive
the securities, cash and property set forth in this Section 9 upon any
conversion or exercise following such event. This provision shall similarly
apply to successive such events.
(e) DILUTION.
(i) GENERAL - ADJUSTMENTS FOR COMMON STOCK AND CONVERTIBLE SECURITIES
ISSUED OR VALUED AT LESS THAN $0.20 PER SHARE. If the Company shall issue,
at any time after the date hereof and before the exercise by Holder of this
Warrant and any warrants issued pursuant to this Section 9(e), any Common
Stock, warrants, options, or similar rights to acquire Common Stock at an
issue price, exercise price or value less than $0.20 per share, and
following such securities issuance the shares of Common Stock issuable to
Holder under Warrant No. 1, Warrant No. 2, this Warrant and any warrants
issued pursuant to this Section 9(e), in the aggregate, represents less
than thirty percent (30%) of the Common Stock that is issued and
outstanding as of the date of such securities issuance, on a fully diluted
basis assuming the conversion or exchange of all outstanding convertible
securities of the Company and the exercise of all outstanding options,
warrants or similar rights to acquire Common Stock, then the Company shall
issue to Holder (without the payment of additional consideration)
additional warrants, in the same form as this Warrant (and with the same
expiration date), so that the number of shares of Common Stock that Holder
may acquire pursuant to Warrant No. 1, Warrant No. 2, this Warrant and any
warrants issued pursuant to this Section 9(e), in the aggregate, shall
equal thirty percent (30%) of the Common Stock, on a fully diluted basis,
assuming the conversion or exchange of all outstanding options, warrants or
6
similar rights to acquire Common Stock (except (i) for any unexercised
options issued to employees, officers, directors or consultants
constituting "Option Shares," as defined in Section 3.9 of the Amended Loan
Agreement and (ii) for any shares of Common Stock that the Company sells to
Cornell Capital Partners, LP pursuant to the Standby Equity Distribution
Agreement dated on or about October 25, 2004, the proceeds of which are
directly used to repay the $4.0 million note). Section 1.2(E) of the
Amended Loan Agreement contains the formula for calculating additional
warrant shares issuable under this Section 9(e)(i).
(ii) NO ADJUSTMENTS WITH RESPECT TO EQUITY-BACKED PROMISSORY NOTE
PAYABLE TO CORNELL CAPITAL PARTNERS, LP. Notwithstanding Section 9(e)(i)
above, HoMedics hereby waives its right to receive any additional warrants
which would otherwise be issuable under this Section 9(e) with respect to
shares sold by the Company to Cornell Capital Partners, LP pursuant to the
Standby Equity Distribution Agreement dated on or about October 25, 2004,
the proceeds of which are used directly to pay the $4.0 million promissory
note the Company issued to Cornell Capital Partners dated on or about
October 25, 2004.
(iii) PRICE AT WHICH SHARES OF COMMON STOCK ARE ISSUED OR VALUED. In
the absence of any issue price or exercise price, shares of Common Stock
shall be deemed to be valued at the average closing price of a share of
Common Stock on the OTC BB, or any other quotation system or stock exchange
on which the Common Stock is quoted or listed at the time of exercise, as
reported in "The Wall Street Journal" over the five consecutive trading
days immediately prior to the date of issuance or grant, for purposes of
this Section 9(e).
(f) RECORD DATE; TREASURY SHARES. For the purposes of this Section 9,
the following clauses shall also be applicable:
(i) RECORD DATE. In case the Company shall take a record of the
holders of its Common Stock for the purpose of entitling them (A) to
receive a dividend or other distribution payable in Common Stock or in
securities convertible or exchangeable into shares of Common Stock, or (B)
to subscribe for or purchase Common Stock or securities convertible or
exchangeable into shares of Common Stock, then such record date shall be
deemed to be the date of the issue or sale of the shares of Common Stock
deemed to have been issued or sold upon the declaration of such dividend or
the making of such other distribution or the date of the granting of such
right of subscription or purchase, as the case may be.
7
(ii) TREASURY SHARES. The number of shares of Common Stock
outstanding at any given time shall not include shares owned or held by or
for the account of the Company, and the disposition of any such shares
shall be considered an issue or sale of Common Stock.
(g) CALCULATIONS; ROUNDING. All calculations under this Section 9
shall be made to the nearest cent or the nearest 1/100th of a share, as the case
may be.
(h) NOTICE TO HOLDER OF EVENTS TRIGGERING ADJUSTMENTS OF THE EXERCISE
PRICE. If:
(i) the Company shall declare a stock dividend (or any other
distribution) on its Common Stock; or
(ii) the Company shall declare a special nonrecurring cash
dividend on or a redemption of its Common Stock; or
(iii) the Company shall authorize the granting to all holders of
the Common Stock rights or warrants to subscribe for or purchase any shares
of capital stock of any class or of any rights; or
(iv) the approval of any stockholders of the Company shall be
required in connection with any reclassification of the Common Stock, any
consolidation or merger to which the Company is a party, any sale or
transfer of all or substantially all of the assets of the Company, or any
compulsory share exchange whereby the Common Stock is converted into other
securities, cash or property; or
(v) the Company shall authorize the voluntary dissolution,
liquidation or winding up of the affairs of the Company;
then the Company shall cause to be mailed to the Holder, at least 20 calendar
days prior to the applicable record or effective date hereinafter specified, a
notice stating (x) the date on which a record is to be taken for the purpose of
such dividend, distribution, redemption, rights or warrants, or if a record is
not to be taken, the date as of which the holders of Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are
to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or
close, and the date as of which it is expected that holders of Common Stock of
record shall be entitled to exchange their shares of Common Stock for
securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer, share exchange, dissolution, liquidation
or winding up.
(i) CERTIFICATE AS TO ADJUSTMENTS. In case of any adjustment in the
Exercise Price or number and type of securities issuable on the exercise of this
Warrant, the Company will promptly give written notice thereof to the Holder in
the form of a certificate, certified and confirmed by an officer of the Company,
setting forth such adjustment and showing in reasonable detail the facts upon
which such adjustment is based.
8
10. REPRESENTATIONS AND COVENANTS OF HOMEDICS.
This Warrant has been granted by the Company in reliance upon the
following representations and covenants of HoMedics:
(a) INVESTMENT PURPOSE. This Warrant and the Common Stock issuable
upon exercise of HoMedics' rights contained herein will be acquired for
investment for HoMedics' own account, and not as a nominee or agent and not with
a view to the distribution of any part thereof. HoMedics further represents that
it does not have any contract, undertaking agreement or arrangement with any
person to sell, transfer or grant participations to such person, or to any third
person, with respect to this Warrant.
(b) PRIVATE ISSUE. HoMedics understands (i) that the Warrant and the
Common Stock issuable upon exercise of this Warrant are not registered under the
1933 Act, or qualified under applicable state securities laws on the ground that
the issuance of this Warrant will be exempt from the registration and
qualification requirements thereof, and (ii) that the Company's reliance on such
exemption is predicated on the representations set forth in this Section 10.
(c) SALES OF COMMON STOCK. HoMedics acknowledges that in the event the
applicable requirements of Rule 144 are not met, registration under the 1933 Act
or compliance with another exemption from registration will be required for any
disposition of the Common Stock issuable upon exercise of this Warrant.
(d) FINANCIAL RISK. HoMedics has such knowledge and experience in
financial and business matters as to be capable of evaluating the merits and
risks of its investment, and has the ability to bear the economic risks of its
investment.
(e) ACCREDITED INVESTOR. HoMedics is an "accredited investor" within
the meaning of Rule 501 of Regulation D promulgated under the 1933 Act.
11. REGISTRATION RIGHTS AGREEMENT.
The shares issuable upon exercise of this Warrant are subject to an
Amended and Restated Registration Rights Agreement between the Company and
HoMedics dated October 25, 2004 (the "REGISTRATION RIGHTS AGREEMENT").
12. GOVERNING LAW.
This Warrant shall be governed by and construed in accordance with the
laws of the State of Michigan applicable to contracts made and to be performed
wholly within such state. Any action or proceeding arising under or pursuant to
this Warrant shall be brought in the appropriate court in the State of Michigan.
9
13. COMPLETE AGREEMENT AND MODIFICATIONS.
This Warrant No. 3, Warrant No. 1, Warrant No. 2, the Loan Agreement,
the Amended Loan Agreement, all documents that appear as Exhibits to the Loan
Agreement and the Amended Loan Agreement and the Registration Rights Agreement
constitute the Company's and HoMedics' entire agreement with respect to the
subject matter hereof and supersede all agreements, representations, warranties,
statements, promises and understandings, whether oral or written, with respect
to the subject matter hereof. This Warrant may not be amended, altered or
modified except by a writing signed by the Company and the Holder.
14. NOTICES.
Except as otherwise provided herein, all notices under this Warrant
shall be in writing and shall be delivered by personal service, facsimile,
courier service promising overnight delivery or certified mail (if such service
is not available, then by first class mail), postage prepaid. Notices shall be
addressed as follows:
If to the Holder
of this Warrant: HoMedics, Inc.
3000 N. Pontiac Trail
Commerce Township, MI 48390-2720
Attention: Ron Ferber
Facsimile: (248) 863-3199
With a copy to: Seyburn, Kahn, Ginn, Bess and Serlin, P.C.
2000 Town Center
Suite 1500
Southfield, Michigan 48075-1195
Attention: Alan M. Stillman, Esq.
Facsimile: (248) 353-3727
If to the Company: Kronos Advanced Technologies, Inc.
464 Common Street, Suite 301
Belmont, MA 02478-2570
Attention: Daniel Dwight
Facsimile: (617) 993-9985
With a copy to: Kirkpatrick & Lockhart LLP
201 South Biscayne Boulevard, Suite 2000
Miami, Florida 33131
Attention: Clayton E. Parker, Esq.
10
Facsimile: (305) 358-7095
15. WAIVERS STRICTLY CONSTRUED.
With regard to any power, remedy or right provided herein or otherwise
available to any party hereunder (i) no waiver or extension of time shall be
effective unless expressly contained in a writing signed by the waiving party;
and (ii) no alteration, modification or impairment shall be implied by reason of
any previous waiver, extension of time, delay or omission in exercise, or other
indulgence.
16. SEVERABILITY.
The validity, legality or enforceability of the remainder of this
Warrant shall not be affected even if one or more of its provisions shall be
held to be invalid, illegal or unenforceable in any respect.
11
IN WITNESS WHEREOF, the Company has caused this Warrant to be executed
by its duly authorized officer.
Dated: October 25, 2004
KRONOS ADVANCED TECHNOLOGIES, INC.
By:
----------------------------------------
Name:
Title:
ACKNOWLEDGED AND AGREED:
FKA DISTRIBUTING CO.,
d/b/a HoMedics, Inc.
By: -----------------------------
Name:
Title:
12
NOTICE OF EXERCISE
- ------------------
To: KRONOS ADVANCED TECHNOLOGIES, INC.
(1) [ ] The undersigned hereby elects to purchase __________ shares of
Common Stock of Kronos Advanced Technologies, Inc. pursuant to the terms of the
attached Warrant, and tenders herewith payment of the purchase price in full.
[ ] The undersigned hereby elects to purchase __________ shares of
Common Stock of Kronos Advanced Technologies, Inc. pursuant to the terms of the
attached Warrant, and tenders herewith as a "cashless exercise" the attached
Warrant to purchase _________ shares of Common Stock.
(2) Please issue a certificate or certificates representing said shares in
the name of the undersigned or in such other name as is specified below:
_____________________________________
(Name)
_____________________________________
(Address)
(3) The undersigned represents that the aforesaid shares are being acquired
for the account of the undersigned for investment and not with a view to, or for
resale in connection with, the distribution thereof and that the undersigned has
no present intention of distributing or reselling such shares, except in
compliance with applicable federal and state securities laws.
FKA DISTRIBUTING CO.,
d/b/a HOMEDICS, INC.
__________________________________ ____________________________________
(Date) Name:
Title:
13